CCL5 and Atherosclerotic lesion: On the other hand, CCL5 (RANTES) is secreted by activated platelets and ECs and interacts with several receptors (CCR1, CCR3, CCR5), mediating monocyte/macrophage infiltration in atherosclerotic lesions [359].